Physicians' Academy for Cardiovascular Education

Heart rate elevations over time predict a higher CV risk in HFpEF

Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction - From the TOPCAT Study

Vazir A, Claggett B, Pitt B, et al. - J Am Coll Cardiol HF 2017; published online ahead of print

Background

Studies have shown that an increase in heart rate (HR) over time was associated with a higher risk for adverse events in subjects without known CVD, and in subjects with hypertension and HF [1-4]. The prognostic value of baseline HR and change in HR over time in patients with HFpEF is, however, not known. This analysis of the TOPCAT study [5] aimed to determine whether baseline resting HR, time-updated resting HR and temporal changes in HR from the preceding visit are of prognostic importance in patients with HFpEF.

This analysis of the TOPCAT study concerned 1767 patients with HFpEF, defined as symptomatic HF and an LVEF ≥45%, with either an admission with decompensated HF in the past 12 months or elevated natriuretic peptide, and assigned to either spironolactone (15 to 45 mg/day) or placebo. The primary outcome was a composite of CV death, aborted cardiac arrest, or HF hospitalization.

To assess the temporal change in HR, a time-updated covariate was created, named “HR at any visit”, representing the most recent available HR value for each patient at each visit over the course of the trial. There were up to 16 trial visits in the program, with a median time interval of 135 days (IQR: 61-182 days), and the resting HR was updated up to 15 times after baseline for each patient. The temporal change in resting HR was calculated from the preceding visit by subtracting the time-updated visit HR value from the value of the preceding visit. These changes in HR reflect changes occurring between visits.

Main results

Conclusion

In patients with HFpEF, including those with AF, a higher baseline resting HR and time-updated HR, and an increase in resting HR over time from the preceding clinic visit were independently associated with an elevated risk for CV events. However, a decline in HR over time was not associated with a lower risk for CV events. These findings support the importance of measuring resting HR in everyday clinical practice, to identify HFpEF patients at higher risk for readmission and death.

References

Show references

Find this article online at